Targeted Chemotherapy, the Medical Ecosystem, and the Future of American Health Care

Perspectives in Biology and Medicine 57 (2):268-284 (2014)
  Copy   BIBTEX

Abstract

In light of the central role that medications play in medical progress, the declining rate of new drug development over the past decade is cause for concern . Without important breakthroughs in drug discovery, the future will not be auspicious for the many people suffering from chronic and incurable illnesses. The sluggish pace of pharmaceutical innovation has been particularly characteristic of the largest drug manufacturers, which have generally focused their energies on potential blockbuster medications, those that can generate over $1 billion in annual revenue . Given Pharma’s struggles, the success of the country’s largest drug manufacturer in bringing the ..

Other Versions

No versions found

Links

PhilArchive

    This entry is not archived by us. If you are the author and have permission from the publisher, we recommend that you archive it. Many publishers automatically grant permission to authors to archive pre-prints. By uploading a copy of your work, you will enable us to better index it, making it easier to find.

    Upload a copy of this work     Papers currently archived: 102,217

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Medication of the mind.Scott Veggeberg - 1996 - New York: H. Holt.
Drug Development Failure: How GLP-1 Development Was Abandoned in 1990.Jeffrey S. Flier - 2024 - Perspectives in Biology and Medicine 67 (3):325-336.

Analytics

Added to PP
2014-12-28

Downloads
40 (#578,709)

6 months
8 (#502,503)

Historical graph of downloads
How can I increase my downloads?

References found in this work

No references found.

Add more references